• / Free eNewsletters & Magazine
  • / My Account
Home>$844.6 Bn Recombinant DNA Technology Market Analysis to 2025 - Therapeutic Agent, Vaccine, Biotech Crops, Specialty Chemicals - Research and Markets

$844.6 Bn Recombinant DNA Technology Market Analysis to 2025 - Therapeutic Agent, Vaccine, Biotech Crops, Specialty Chemicals - Research and Markets

$844.6 Bn Recombinant DNA Technology Market Analysis to 2025 - Therapeutic Agent, Vaccine, Biotech Crops, Specialty Chemicals - Research and Markets

09/28/2017

$844.6 Bn Recombinant DNA Technology Market Analysis to 2025 - Therapeutic Agent, Vaccine, Biotech Crops, Specialty Chemicals - Research and Markets

The "Recombinant DNA Technology Market Analysis by Product (Therapeutic Agent, Vaccine, Biotech Crops, Specialty Chemicals), by Component, by Application, by End-use and Segment Forecasts, 2014 - 2025" report has been added to Research and Markets' offering.

The global recombinant DNA technology market is expected to reach USD 844.6 billion by 2025.

Success of genetically engineered human insulin in diabetes treatment has triggered the development of many other recombinant therapeutics and drugs. This has translated to the huge success of Recombinant DNA (rDNA) technology. This technology has offered significant prospects for elucidating the gap between disease and its effective treatment.

Widespread successful application of this technique in veterinary product development, genetically modified crop development, bio pesticides & biofuel production, and gene therapy, are expected to spur the adoption of this technology throughout the forecast period.

Use of Genetically Modified (GM) products, such as GM animals, developed using rDNA method are found to be indispensable to accelerate medical research. Furthermore, more than 3000 scientific studies have been carried out to assess the GM products safety in context to its impact on human health and environment.

In addition, there is rising need to improve the recombinant proteins' production capacity by several folds, owing to increase in demand for effective therapeutics for disease treatment. The aforementioned fact pronounces the technological advances in this sector thus driving growth.

As per Monsanto and other proponents of GM crops, genetic engineering is one of the fastest and widely adopted agricultural innovations over the past few years. This, in turn, is expected bolster the adoption of rDNA technology for non-traditional applications.

©2017 Morningstar Advisor. All right reserved.